258 related articles for article (PubMed ID: 17854073)
1. Studies on the crystal forms of pefloxacin: preparation, characterization, and dissolution profile.
Yadav MR; Shaikh AR; Ganesan V; Giridhar R; Chadha R
J Pharm Sci; 2008 Jul; 97(7):2637-48. PubMed ID: 17854073
[TBL] [Abstract][Full Text] [Related]
2. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
Khan GM; Jiabi Z
Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
[TBL] [Abstract][Full Text] [Related]
4. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
Bukovec P; Benkic P; Smrkolj M; Vrecer F
Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
[TBL] [Abstract][Full Text] [Related]
5. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
[TBL] [Abstract][Full Text] [Related]
6. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
[TBL] [Abstract][Full Text] [Related]
7. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
8. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
9. Investigation of moricizine hydrochloride polymorphs.
Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
[TBL] [Abstract][Full Text] [Related]
10. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method.
Li XS; Wang JX; Shen ZG; Zhang PY; Chen JF; Yun J
Int J Pharm; 2007 Sep; 342(1-2):26-32. PubMed ID: 17566675
[TBL] [Abstract][Full Text] [Related]
11. Characterization of polymorphic ampicillin forms.
Baraldi C; Tinti A; Ottani S; Gamberini MC
J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
[TBL] [Abstract][Full Text] [Related]
12. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
Tao T; Zhao Y; Wu J; Zhou B
Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of dissolution profile by solid dispersion (kneading) technique.
Modi A; Tayade P
AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
[TBL] [Abstract][Full Text] [Related]
15. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
18. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
[TBL] [Abstract][Full Text] [Related]
19. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
Wu K; Li J; Wang W; Winstead DA
J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
[TBL] [Abstract][Full Text] [Related]
20. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]